The DOI matches its Crossref record; the references it cites are not checked yet.
Network approach in liquidomics landscape
Open accessAbstract
Tissue-based biopsy is the present main tool to explore the molecular landscape of cancer, but it also has many limits to be frequently executed, being too invasive with the risk of side effects. These limits and the ability of cancer to constantly evolve its genomic profile, have recently led to the need of a less invasive and more accurate alternative, such as liquid biopsy. By searching Circulating Tumor Cells and residues of their nucleic acids or other tumor products in body fluids, especially in blood, but also in urine, stools and saliva, liquid biopsy is becoming the future of clinical oncology. Despite the current lack of a standardization for its workflows, that makes it hard to be reproduced, liquid biopsy has already obtained promising results for cancer screening, diagnosis, prognosis, and risk of recurrence.Through a more accessible molecular profiling of tumors, it could become easier to identify biomarkers predictive of response to treatment, such as EGFR mutations in non-small cell lung cancer and KRAS mutations in colorectal cancer, or Microsatellite Instability and Mismatch Repair as predictive markers of pembrolizumab response.By monitoring circulating tumor DNA in longitudinal repeated sampling of blood we could also predict Minimal Residual Disease and the risk of recurrence in already radically resected patients.In this review we will discuss about the current knowledge of limitations and strengths of the different forms of liquid biopsies for its inclusion in normal cancer management, with a brief nod to their newest biomarkers and its future implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 385 · Cited by 37
Research works printed but not linked: 2
- Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18(5):297–312. · DOI · Paper page
- Liu H, Gong W, Lou J, Ju H, Yin X, Liu Y, et al. MicroRNA-21 and microRNA-146a identification in stool and its clinical significance in colorectal neoplasms. 2016;9:16441–9
Metadata
- Authors
- Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., Fazio, F., Scagnoli, S., Pomati, G., Pantano, F., Perrone, G., De Falco, E., Russo, A., & Spinelli, G. P.
- Affiliations
- Sapienza University of Rome (IT)
- University of Palermo (IT)
- Università Campus Bio-Medico (IT)
- Corresponding author
- Fazio, Federico
- ORCID
- Venue
- Journal of Experimental & Clinical Cancer Research
- Published
- 2023-08-04
- Volume
- 42
- Issue
- 1
- Pages
- 193-193
- ISSN
- 0392-9078 (ISSN-L)
- 1756-9966
- PMC
- PMC10401883
- OpenAlex
- W4385582133
- Cited by
- 37
- References
- 385
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 16 · 2023: 5
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Keywords
- liquid biopsy, circulating tumor cells, circulating tumor DNA, tumor markers, predictive biomarkers, minimal residual disease, tumor recurrence, cancer screening, cancer diagnosis, treatment response prediction, EGFR mutation, KRAS mutation, microsatellite instability, network analysis
- MeSH terms
- Liquid Biopsy, Circulating Tumor DNA, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Biomarkers, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Network approach in liquidomics landscape. https://app.cochat.ai/papers/10.1186/s13046-023-02743-9
- The paper
- Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., Fazio, F., Scagnoli, S., Pomati, G., Pantano, F., Perrone, G., De Falco, E., Russo, A., & Spinelli, G. P. (2023). Network approach in liquidomics landscape. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-023-02743-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
